Skip to content
← Back to this collection

PUBLICATIONS · 27908454

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Dec 17
First author
Robertson JFR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Dec 17;388(10063):2961-2962. doi: 10.1016/S0140-6736(16)32418-7.
    note
    Source null
    related pmid
    27908455
    relationship
    Comment in

Authors and identifiers

  1. name
    Robertson JFR
    type
    Author
  2. name
    Bondarenko IM
    type
    Author
  3. name
    Trishkina E
    type
    Author
  4. name
    Dvorkin M
    type
    Author
  5. name
    Panasci L
    type
    Author
  6. name
    Manikhas A
    type
    Author
  7. name
    Shparyk Y
    type
    Author
  8. name
    Cardona-Huerta S
    type
    Author
  9. name
    Cheung KL
    type
    Author
  10. name
    Philco-Salas MJ
    type
    Author
  11. name
    Ruiz-Borrego M
    type
    Author
  12. name
    Shao Z
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Robertson JFR
    type
    Author
  2. name
    Bondarenko IM
    type
    Author
  3. name
    Trishkina E
    type
    Author
  4. name
    Dvorkin M
    type
    Author
  5. name
    Panasci L
    type
    Author
  6. name
    Manikhas A
    type
    Author
  7. name
    Shparyk Y
    type
    Author
  8. name
    Cardona-Huerta S
    type
    Author
  9. name
    Cheung KL
    type
    Author
  10. name
    Philco-Salas MJ
    type
    Author
  11. name
    Ruiz-Borrego M
    type
    Author
  12. name
    Shao Z
    type
    Author
bibliography ids
  1. nci-bib-1a2947424daac7ef7a9d2e9c
book metadata
content sha256
9f3880641ccda74c3601e6ee7f66d831b57348fa698c18c604ea2a64cd432576
document type
citation
dois
  1. 10.1016/S0140-6736(16)32389-3
electronic publication date
display
2016 Nov 29
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27908454
immutable id
pubmed:27908454@9f3880641ccda74c3601e6ee7f66d831b57348fa698c18c604ea2a64cd432576
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10063
name
Lancet (London, England)
nlm unique id
2985213R
pages
2997-3005
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Dec 17;388(10063):2961-2962. doi: 10.1016/S0140-6736(16)32418-7.
    note
    Source null
    related pmid
    27908455
    relationship
    Comment in
outcomes validated
false
pmid
27908454
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
d256bd0f9c0f6a9f0ade9594eba9a0d0117bc65bee6ccf9129d8940bb54b6b01
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2016 Dec 17
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27908454/
title
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.

Preserved source evidence · Not medical advice